The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gene Editing Market Research Report 2024
Synopsis
Gemstones are elements of minerals which when polished and cut are used for making jewelry and other ornaments, as well as for decoration purposes.
The global Gene Editing market was valued at US$ 3093.1 million in 2023 and is anticipated to reach US$ 5441.3 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030.
Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.
This report aims to provide a comprehensive presentation of the global market for Gene Editing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Editing.
Report Scope
The Gene Editing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Editing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Editing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Merck
Horizon Discovery
Sangamo BioSciences
Integrated DNA Technologies
Lonza
New England Biolabs
OriGene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
CRISPR Therapeutics
RGen Solutions
Sigma-Aldrich
GeneCopoeia
Genscript Biotech
Segment by Type
Zinc finger nucleases (ZFNs)
Transcription Activator-Like Effector-based Nucleases (TALENs)
CRISPR-Cas system
Segment by Application
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Contract Research Organizations
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Editing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Gemstones are elements of minerals which when polished and cut are used for making jewelry and other ornaments, as well as for decoration purposes.
The global Gene Editing market was valued at US$ 3093.1 million in 2023 and is anticipated to reach US$ 5441.3 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030.
Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.
This report aims to provide a comprehensive presentation of the global market for Gene Editing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Editing.
Report Scope
The Gene Editing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Editing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Editing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Merck
Horizon Discovery
Sangamo BioSciences
Integrated DNA Technologies
Lonza
New England Biolabs
OriGene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
CRISPR Therapeutics
RGen Solutions
Sigma-Aldrich
GeneCopoeia
Genscript Biotech
Segment by Type
Zinc finger nucleases (ZFNs)
Transcription Activator-Like Effector-based Nucleases (TALENs)
CRISPR-Cas system
Segment by Application
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Contract Research Organizations
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Editing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Editing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Zinc finger nucleases (ZFNs)
1.2.3 Transcription Activator-Like Effector-based Nucleases (TALENs)
1.2.4 CRISPR-Cas system
1.3 Market by Application
1.3.1 Global Gene Editing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology & Pharmaceutical Companies
1.3.3 Academic & Government Research Institutes
1.3.4 Contract Research Organizations
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Editing Market Perspective (2019-2030)
2.2 Gene Editing Growth Trends by Region
2.2.1 Global Gene Editing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Editing Historic Market Size by Region (2019-2024)
2.2.3 Gene Editing Forecasted Market Size by Region (2025-2030)
2.3 Gene Editing Market Dynamics
2.3.1 Gene Editing Industry Trends
2.3.2 Gene Editing Market Drivers
2.3.3 Gene Editing Market Challenges
2.3.4 Gene Editing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Editing Players by Revenue
3.1.1 Global Top Gene Editing Players by Revenue (2019-2024)
3.1.2 Global Gene Editing Revenue Market Share by Players (2019-2024)
3.2 Global Gene Editing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Editing Revenue
3.4 Global Gene Editing Market Concentration Ratio
3.4.1 Global Gene Editing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Editing Revenue in 2023
3.5 Gene Editing Key Players Head office and Area Served
3.6 Key Players Gene Editing Product Solution and Service
3.7 Date of Enter into Gene Editing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Editing Breakdown Data by Type
4.1 Global Gene Editing Historic Market Size by Type (2019-2024)
4.2 Global Gene Editing Forecasted Market Size by Type (2025-2030)
5 Gene Editing Breakdown Data by Application
5.1 Global Gene Editing Historic Market Size by Application (2019-2024)
5.2 Global Gene Editing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Editing Market Size (2019-2030)
6.2 North America Gene Editing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Editing Market Size by Country (2019-2024)
6.4 North America Gene Editing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Editing Market Size (2019-2030)
7.2 Europe Gene Editing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Editing Market Size by Country (2019-2024)
7.4 Europe Gene Editing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Editing Market Size (2019-2030)
8.2 Asia-Pacific Gene Editing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Editing Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene Editing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Editing Market Size (2019-2030)
9.2 Latin America Gene Editing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Editing Market Size by Country (2019-2024)
9.4 Latin America Gene Editing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Editing Market Size (2019-2030)
10.2 Middle East & Africa Gene Editing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Editing Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene Editing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Gene Editing Introduction
11.1.4 Thermo Fisher Scientific Revenue in Gene Editing Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Gene Editing Introduction
11.2.4 Merck Revenue in Gene Editing Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Horizon Discovery
11.3.1 Horizon Discovery Company Detail
11.3.2 Horizon Discovery Business Overview
11.3.3 Horizon Discovery Gene Editing Introduction
11.3.4 Horizon Discovery Revenue in Gene Editing Business (2019-2024)
11.3.5 Horizon Discovery Recent Development
11.4 Sangamo BioSciences
11.4.1 Sangamo BioSciences Company Detail
11.4.2 Sangamo BioSciences Business Overview
11.4.3 Sangamo BioSciences Gene Editing Introduction
11.4.4 Sangamo BioSciences Revenue in Gene Editing Business (2019-2024)
11.4.5 Sangamo BioSciences Recent Development
11.5 Integrated DNA Technologies
11.5.1 Integrated DNA Technologies Company Detail
11.5.2 Integrated DNA Technologies Business Overview
11.5.3 Integrated DNA Technologies Gene Editing Introduction
11.5.4 Integrated DNA Technologies Revenue in Gene Editing Business (2019-2024)
11.5.5 Integrated DNA Technologies Recent Development
11.6 Lonza
11.6.1 Lonza Company Detail
11.6.2 Lonza Business Overview
11.6.3 Lonza Gene Editing Introduction
11.6.4 Lonza Revenue in Gene Editing Business (2019-2024)
11.6.5 Lonza Recent Development
11.7 New England Biolabs
11.7.1 New England Biolabs Company Detail
11.7.2 New England Biolabs Business Overview
11.7.3 New England Biolabs Gene Editing Introduction
11.7.4 New England Biolabs Revenue in Gene Editing Business (2019-2024)
11.7.5 New England Biolabs Recent Development
11.8 OriGene Technologies
11.8.1 OriGene Technologies Company Detail
11.8.2 OriGene Technologies Business Overview
11.8.3 OriGene Technologies Gene Editing Introduction
11.8.4 OriGene Technologies Revenue in Gene Editing Business (2019-2024)
11.8.5 OriGene Technologies Recent Development
11.9 Transposagen Biopharmaceuticals
11.9.1 Transposagen Biopharmaceuticals Company Detail
11.9.2 Transposagen Biopharmaceuticals Business Overview
11.9.3 Transposagen Biopharmaceuticals Gene Editing Introduction
11.9.4 Transposagen Biopharmaceuticals Revenue in Gene Editing Business (2019-2024)
11.9.5 Transposagen Biopharmaceuticals Recent Development
11.10 Editas Medicine
11.10.1 Editas Medicine Company Detail
11.10.2 Editas Medicine Business Overview
11.10.3 Editas Medicine Gene Editing Introduction
11.10.4 Editas Medicine Revenue in Gene Editing Business (2019-2024)
11.10.5 Editas Medicine Recent Development
11.11 CRISPR Therapeutics
11.11.1 CRISPR Therapeutics Company Detail
11.11.2 CRISPR Therapeutics Business Overview
11.11.3 CRISPR Therapeutics Gene Editing Introduction
11.11.4 CRISPR Therapeutics Revenue in Gene Editing Business (2019-2024)
11.11.5 CRISPR Therapeutics Recent Development
11.12 RGen Solutions
11.12.1 RGen Solutions Company Detail
11.12.2 RGen Solutions Business Overview
11.12.3 RGen Solutions Gene Editing Introduction
11.12.4 RGen Solutions Revenue in Gene Editing Business (2019-2024)
11.12.5 RGen Solutions Recent Development
11.13 Sigma-Aldrich
11.13.1 Sigma-Aldrich Company Detail
11.13.2 Sigma-Aldrich Business Overview
11.13.3 Sigma-Aldrich Gene Editing Introduction
11.13.4 Sigma-Aldrich Revenue in Gene Editing Business (2019-2024)
11.13.5 Sigma-Aldrich Recent Development
11.14 GeneCopoeia
11.14.1 GeneCopoeia Company Detail
11.14.2 GeneCopoeia Business Overview
11.14.3 GeneCopoeia Gene Editing Introduction
11.14.4 GeneCopoeia Revenue in Gene Editing Business (2019-2024)
11.14.5 GeneCopoeia Recent Development
11.15 Genscript Biotech
11.15.1 Genscript Biotech Company Detail
11.15.2 Genscript Biotech Business Overview
11.15.3 Genscript Biotech Gene Editing Introduction
11.15.4 Genscript Biotech Revenue in Gene Editing Business (2019-2024)
11.15.5 Genscript Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
